摘要
目的:研究Th22细胞及IL-22分子在原发性肝细胞肝癌发生发展中的表达及意义。方法:选取2015年1月至2016年12月于温州医科大学附属第三医院住院治疗的慢性乙肝肝硬化患者42例(肝硬化组),肝癌伴乙肝肝硬化患者38例(肝癌组),及门诊健康受检者30例(健康对照组),慢性乙型肝炎患者21例(慢性乙肝组)。收集各组谷草转氨酶(AST)、谷丙转氨酶(ALT)、总胆红素(TBIL)和白蛋白(ALB)信息,并分别收集清晨空腹肘静脉血2份,一份用ELISA方法测定IL-22表达水平,另一份用流式细胞仪测定Th22细胞含量。统计分析各组指标的差异。结果:肝硬化组和肝癌组患者的AST、ALT、TBIL和ALB显著高于慢性乙肝组和健康对照组(P<0.01),肝癌组患者AST、ALT、TBIL和ALB高于乙肝肝硬化组(P<0.01),慢性乙肝组和健康对照组间AST、ALT、TBIL和ALB差异无统计学意义(P>0.05)。此外,随着肝癌的发生发展,AST、ALT、TBIL和ALB逐渐升高(P<0.05)。肝硬化组及肝癌组的Th22细胞含量及IL-22表达水平均高于慢性乙肝组和健康对照组(P<0.05),肝癌组的Th22细胞含量及IL-22表达水平高于肝硬化组(P<0.05),慢性乙肝组的Th22细胞含量及IL-22表达水平与健康对照组差异无统计学意义(P>0.05)。随着肝癌的发生发展,Th22细胞含量及IL-22表达水平逐渐升高(P<0.05)。结论:Th22及IL-22水平可能与肝癌的发生发展具有相关性。
Objective: To study the expression and significance of Th22 cells and IL-22 in the development and progression of primary hepatocellular carcinoma.Methods: A total of 42 hospitalized patients with chronic hepatitis B cirrhosis (cirrhosis group),38 hospitalized patients with hepatocellular carcinoma (hepatocellular carcinoma group),30 healthy volunteers (healthy group) and 21 cases of chronic hepatitis B (CHB group) were randomly selected from the Third Affiliated Hospital of Wenzhou Medical University from January 2015 to December 2016.The differences in AST,ALT,TBIL and ALB values were analyzed.Blood was collected intravenously into 2 heparin anticoagulant tubes,one for testing IL-22 expression level and the other for determination of Th22 cell levels using flow cytometry.The statistics of Th22 and IL-22 levels were analyzed.Results: The AST,ALT,TBIL and ALB values in patients with cirrhosis and hepatocellular carcinoma were significantly higher than those in the CHB group and healthy group (P<0.01).The AST,ALT,TBIL and ALB values of patients in the hepatocellular carcinoma group were higher than those in cirrhosis group (P<0.01).There was no significant difference between CHB group and healthy group (P>0.05).In addition,the AST,ALT,TBIL and ALB gradually increased with the development of hepatocellular carcinoma (P<0.05).The levels of Th22 and IL-22 in liver cirrhosis group and hepatocellular carcinoma group were higher than those in healthy subjects (P<0.05).Th22 and IL-22 levels in hepatitis B liver cancer group were higher than those in hepatitis B cirrhosis group (P<0.05).The levels of Th22 and IL-22 were gradually increased with the development of hepatocellular carcinoma (P<0.05).Conclusion: Th22 and IL-22 may be related to the occurrence and development of HCC.
作者
施振静
吴道义
吴丽丽
乔彬彬
郑冰汝
李成
施昌盛
虞希祥
SHI Zhenjing;WU Daoyi;WU Lili;QIAO Binbin;ZHENG Bingru;LI Cheng;SHI Changsheng;YU Xixiang(Department of Interventional Medicine, the Third Affiliated Hospital of Wenzhou Medical University, Wenzhou 325200, China;Department of Gastrointestinal Surgery, the Third Affiliated Hospital of Wenzhou Medical University, Wenzhou 325200, China;Department of Radiochemotherapy,the Third Affiliated Hospital of Wenzhou Medical University, Wenzhou 325200, China;Department of Oncology, Ningling People’s Hospital, Shangqiu 310006, China;Department of Vasointerventional Surgery,the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China;Department of Vasointerventional Surgery, Wenzhou People’s Hospital, Wenzhou 325699, China)
出处
《温州医科大学学报》
CAS
2019年第1期15-19,共5页
Journal of Wenzhou Medical University
基金
浙江省医药卫生科技计划项目(2015KYB369)
瑞安市科技创新专项资金(MS2015014
MS2015012
MS2015020)
